BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 9070732)

  • 1. Future pregnancy outcome in unexplained recurrent first trimester miscarriage.
    Clifford K; Rai R; Regan L
    Hum Reprod; 1997 Feb; 12(2):387-9. PubMed ID: 9070732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of reproductive outcomes of women with two consecutive miscarriages and no living child.
    Green DM; O'Donoghue K
    J Obstet Gynaecol; 2019 Aug; 39(6):816-821. PubMed ID: 31006300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-visualized pregnancy losses are prognostically important for unexplained recurrent miscarriage.
    Kolte AM; van Oppenraaij RH; Quenby S; Farquharson RG; Stephenson M; Goddijn M; Christiansen OB;
    Hum Reprod; 2014 May; 29(5):931-7. PubMed ID: 24603132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent MiscarriageGreen-top Guideline No. 17.
    Regan L; Rai R; Saravelos S; Li TC;
    BJOG; 2023 Nov; 130(12):e9-e39. PubMed ID: 37334488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High serum luteinizing hormone and testosterone concentrations do not predict pregnancy outcome in women with recurrent miscarriage.
    Nardo LG; Rai R; Backos M; El-Gaddal S; Regan L
    Fertil Steril; 2002 Feb; 77(2):348-52. PubMed ID: 11821095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High prospective fetal loss rate in untreated pregnancies of women with recurrent miscarriage and antiphospholipid antibodies.
    Rai RS; Clifford K; Cohen H; Regan L
    Hum Reprod; 1995 Dec; 10(12):3301-4. PubMed ID: 8822463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supplementation with progestogens in the first trimester of pregnancy to prevent miscarriage in women with unexplained recurrent miscarriage: a systematic review and meta-analysis of randomized, controlled trials.
    Saccone G; Schoen C; Franasiak JM; Scott RT; Berghella V
    Fertil Steril; 2017 Feb; 107(2):430-438.e3. PubMed ID: 27887710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spontaneous first trimester miscarriage rates per woman among parous women with 1 or more pregnancies of 24 weeks or more.
    Cohain JS; Buxbaum RE; Mankuta D
    BMC Pregnancy Childbirth; 2017 Dec; 17(1):437. PubMed ID: 29272996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent miscarriage and antiphospholipid antibodies: prognosis of subsequent pregnancy.
    Cohn DM; Goddijn M; Middeldorp S; Korevaar JC; Dawood F; Farquharson RG
    J Thromb Haemost; 2010 Oct; 8(10):2208-13. PubMed ID: 20704646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies).
    Rai R; Cohen H; Dave M; Regan L
    BMJ; 1997 Jan; 314(7076):253-7. PubMed ID: 9022487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of thyroid peroxidase antibodies with the rate of first-trimester miscarriage in euthyroid women with unexplained recurrent spontaneous abortion.
    Liu M; Wang D; Zhu L; Yin J; Ji X; Zhong Y; Gao Y; Zhang J; Liu Y; Zhang R; Chen H
    Front Endocrinol (Lausanne); 2022; 13():966565. PubMed ID: 36120428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervical fetal fibronectin as a predictor of first trimester pregnancy outcome in unexplained recurrent miscarriage.
    Mercorio F; Mercorio A; Di Spiezio Sardo A; Votino C; Barba GV; Nappi C
    Eur J Obstet Gynecol Reprod Biol; 2006 Jun; 126(2):165-9. PubMed ID: 16256259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macroscopic and microscopic morphology of first trimester miscarriage and subsequent pregnancy outcome - An exploratory study.
    van Gruting IMA; Müller MA; van Groningen K; Exalto N
    Placenta; 2017 May; 53():16-22. PubMed ID: 28487015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent miscarriage--outcome after supportive care in early pregnancy.
    Liddell HS; Pattison NS; Zanderigo A
    Aust N Z J Obstet Gynaecol; 1991 Nov; 31(4):320-2. PubMed ID: 1799343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Supportive care for women with recurrent miscarriage: a survey to quantify women's preferences.
    Musters AM; Koot YE; van den Boogaard NM; Kaaijk E; Macklon NS; van der Veen F; Nieuwkerk PT; Goddijn M
    Hum Reprod; 2013 Feb; 28(2):398-405. PubMed ID: 23213179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent miscarriage--an aspirin a day?
    Rai R; Backos M; Baxter N; Chilcott I; Regan L
    Hum Reprod; 2000 Oct; 15(10):2220-3. PubMed ID: 11006203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antinuclear autoantibodies and pregnancy outcome in women with unexplained recurrent miscarriage.
    Ticconi C; Pietropolli A; Borelli B; Bruno V; Piccione E; Bernardini S; Di Simone N
    Am J Reprod Immunol; 2016 Nov; 76(5):396-399. PubMed ID: 27616598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perinatal outcomes in a subsequent pregnancy among women who have experienced recurrent miscarriage: a retrospective cohort study.
    Field K; Murphy DJ
    Hum Reprod; 2015 May; 30(5):1239-45. PubMed ID: 25759495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent pregnancy loss evaluation combined with 24-chromosome microarray of miscarriage tissue provides a probable or definite cause of pregnancy loss in over 90% of patients.
    Popescu F; Jaslow CR; Kutteh WH
    Hum Reprod; 2018 Apr; 33(4):579-587. PubMed ID: 29538673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polycystic ovaries and recurrent miscarriage--a reappraisal.
    Rai R; Backos M; Rushworth F; Regan L
    Hum Reprod; 2000 Mar; 15(3):612-5. PubMed ID: 10686206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.